The rule also extends to medically important biologic products.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
In conjunction with the proposed rule, the FDA has sent Congress a plan for improving the FDA’s ability to react in response to drug shortages.
The FDA will accept comments on the rule until Jan. 3, and comments on the information collection requirements until Dec. 4.
More Articles on Quality:
5 Steps for Reducing Inapprorpriate Hospital Admissions
7 Stats on Patient-Controlled Analgesia
New York Healthcare Worker Exposes Babies to TB
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.